Introduction & Agenda

  1. Letter to Participants from Drs. Mikhail Kosiborod and Larry Sperling
  2. Managing CV Disease Risk in Diabetes Roundtable Agenda
  3. Interactive Table Discussion Questions

Cardiovascular Outcomes Trials in T2DM

  1. Novel Diabetes Drugs and the Cardiovascular Specialist (JACC – Sattar et al. 2017)
  2. Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes (AJM – Paneni et al. 2017)
  3. Shifting Paradigms in the Medical Management of Type 2 Diabetes: Reflections on Recent Cardiovascular Outcome Trials (JGIM– Ismail-Belgi et al. 2017)
  4. Cardiovascular safety outcomes of new antidiabetic therapies (AJHP– LeBras et al 2017)

Clinical Guidance

  1. ADA Standards of Medical Care in Diabetes: Chapter 8. Pharmacologic Approaches to Glycemic Treatment (Diabetes Care 2017)
  2. ADA Standards of Medical Care in Diabetes: Chapter 9. Cardiovascular Disease and Risk Management (Diabetes Care 2017)
  3. Clinical Update: Cardiovascular Disease in Diabetes Mellitus Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus – Mechanisms, Management, and Clinical Considerations (Circulation – Low Wang et al. 2016)
  4. Why Don't Diabetes Patients Achieve Recommended Risk Factor Targets? Poor Adherence versus Lack of Treatment Intensification (JGIM – Schmittdiel et al. 2008)
  5. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2017 Executive Summary (Endocrine Practice – Garber et al. 2017)

Care Coordination

  1. 2015 ACC Health Policy Statement on Cardiovascular Team-Based Care and the Role of the Advanced Practice Provider (JACC – Brush, et al. 2015)
  2. The CardioMetabolic Health Alliance: Working Toward a New Care Model for the Metabolic Syndrome (JACC – Sperling et al. 2015)
  3. A National Effort to Prevent Type 2 Diabetes: Participant-Level Evaluation of CDC's National Diabetes Prevention Program (Diabetes Care – Ely et al. 2017)

Diabetes Collaborative Registry

  1. Diabetes Collaborative Registry Data Collection Form
  2. Quality of care of the initial patient cohort of the Diabetes Collaborative Registry presented (ADA.16 – Arnold et al. 2016)
  3. Defining the potential impact of the EMPA-REG OUTCOMES® trial on improving cardiovascular outcomes of patients in the Diabetes Collaborative Registry (EASD.16 – Arnold et al. 2016)
  4. Using The Diabetes Collaborative Registry (DCR) To Estimate the Potential Real-world Impact of The LEADER Trial On Improving Cardiovascular Outcomes in Patients with Diabetes at High Cardiovascular Risk (ACC.17 – Arnold et al. 2017)
  5. Assessing the Personalization of Glycemic Management in Clinical Practice: an Analysis of the Diabetes Collaborative Registry (AHA.16 – Arnold et al. 2016)
  6. Using The Diabetes Collaborative Registry (DCR) To Estimate the Potential Real-world Impact of The IRIS Trial On Improving Outcomes in Patients with Cerebrovascular Disease (AHA.16 – Arnold et al. 2016)
  7. Diabetes Collaborative Registry Methods Manuscript: Improving the Quality of Cardiometabolic Care for Patients with Type 2 Diabetes in the United States (Diabetes Care – Arnold et al. 2017)

Supplemental Reading Not Included in Book  

  1. Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes (EMPA-REG OUTCOME) (NEJM – 2016)
  2. Insulin Resistance Intervention after Stroke (IRIS) (NEJM – 2016)
  3. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes (LEADER) (NEJM – 2016)
  4. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6) (NEJM – 2016)
  5. A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease (BARI 2D) (NEJM – 2009)
  6. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes (CANVAS) (NEJM – 2017)
  7. Provider Interactions and Cost Affect Type 2 Diabetes Mellitus Patients’ Perceptions of Care Quality and Adherence (ADA.17 – Simacek et al. 2017)

Presentations